{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T16:44:04Z","timestamp":1792601044283,"version":"4.5.0"},"reference-count":70,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,10,26]],"date-time":"2017-10-26T00:00:00Z","timestamp":1508976000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006227","name":"LLNL LDRD","doi-asserted-by":"publisher","award":["ER (16-ERD-007)"],"award-info":[{"award-number":["ER (16-ERD-007)"]}],"id":[{"id":"10.13039\/100006227","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006227","name":"U.S. Department of Energy by Lawrence Livermore National Laboratory","doi-asserted-by":"publisher","award":["DE-AC52-07NA27344"],"award-info":[{"award-number":["DE-AC52-07NA27344"]}],"id":[{"id":"10.13039\/100006227","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","metabolismjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.metabol.2017.10.005","type":"journal-article","created":{"date-parts":[[2017,10,25]],"date-time":"2017-10-25T20:00:18Z","timestamp":1508961618000},"page":"38-47","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":79,"special_numbering":"C","title":["Genetics of Sost\/SOST in sclerosteosis and van Buchem disease animal models"],"prefix":"10.1016","volume":"80","author":[{"given":"Aimy","family":"Sebastian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela G.","family":"Loots","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl. 3","key":"10.1016\/j.metabol.2017.10.005_bb0005","doi-asserted-by":"crossref","first-page":"S131","DOI":"10.2215\/CJN.04151206","article-title":"Normal bone anatomy and physiology","volume":"3","author":"Clarke","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"issue":"Suppl. 3","key":"10.1016\/j.metabol.2017.10.005_bb0010","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1016\/j.joca.2010.05.025","article-title":"The OARSI histopathology initiative - recommendations for histological assessments of osteoarthritis in the mouse","volume":"18","author":"Glasson","year":"2010","journal-title":"Osteoarthr Cartil"},{"key":"10.1016\/j.metabol.2017.10.005_bb0015","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1196\/annals.1365.035","article-title":"Bone remodeling","volume":"1092","author":"Hadjidakis","year":"2006","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.metabol.2017.10.005_bb0020","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1007\/s00198-010-1194-5","article-title":"Osteocyte: the unrecognized side of bone tissue","volume":"21","author":"Rochefort","year":"2010","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.metabol.2017.10.005_bb0025","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1196\/annals.1402.018","article-title":"Osteocytes as dynamic multifunctional cells","volume":"1116","author":"Bonewald","year":"2007","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.metabol.2017.10.005_bb0030","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s00223-010-9372-1","article-title":"Sclerostin: current knowledge and future perspectives","volume":"87","author":"Moester","year":"2010","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.metabol.2017.10.005_bb0035","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1034\/j.1399-0004.2003.00036.x","article-title":"The natural history of sclerosteosis","volume":"63","author":"Hamersma","year":"2003","journal-title":"Clin Genet"},{"key":"10.1016\/j.metabol.2017.10.005_bb0040","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.bone.2016.10.010","article-title":"Sclerostin deficiency in humans","volume":"96","author":"van Lierop","year":"2017","journal-title":"Bone"},{"key":"10.1016\/j.metabol.2017.10.005_bb0045","first-page":"209","article-title":"Osteopetrosis with syndactyly; a morphological variant of Albers-Schonberg's disease","volume":"40-B","author":"Truswell","year":"1958","journal-title":"J Bone Joint Surg Br"},{"key":"10.1016\/j.metabol.2017.10.005_bb0050","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1007\/s12020-016-0888-7","article-title":"From disease to treatment: from rare skeletal disorders to treatments for osteoporosis","volume":"52","author":"Appelman-Dijkstra","year":"2016","journal-title":"Endocrine"},{"key":"10.1016\/j.metabol.2017.10.005_bb0055","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1017\/S0022215113002648","article-title":"An auditory profile of sclerosteosis","volume":"128","author":"Potgieter","year":"2014","journal-title":"J Laryngol Otol"},{"key":"10.1016\/j.metabol.2017.10.005_bb0060","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.1002\/jbmr.474","article-title":"Patients with sclerosteosis and disease carriers: human models of the effect of sclerostin on bone turnover","volume":"26","author":"van Lierop","year":"2011","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.metabol.2017.10.005_bb0065","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.1399-0004.1984.tb00481.x","article-title":"The syndromic status of sclerosteosis and van Buchem disease","volume":"25","author":"Beighton","year":"1984","journal-title":"Clin Genet"},{"key":"10.1016\/j.metabol.2017.10.005_bb0070","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3109\/00016925509170789","article-title":"An uncommon familial systemic disease of the skeleton: hyperostosis corticalis generalisata familiaris","volume":"44","author":"Van Buchem","year":"1955","journal-title":"Acta Radiol"},{"key":"10.1016\/j.metabol.2017.10.005_bb0075","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1086\/301721","article-title":"Van Buchem disease (hyperostosis corticalis generalisata) maps to chromosome 17q12-q21","volume":"62","author":"Van Hul","year":"1998","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.metabol.2017.10.005_bb0080","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1093\/hmg\/11.20.2385","article-title":"Molecular genetics of too much bone","volume":"11","author":"Janssens","year":"2002","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.metabol.2017.10.005_bb0085","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1002\/jbmr.1794","article-title":"Van Buchem disease: clinical, biochemical, and densitometric features of patients and disease carriers","volume":"28","author":"van Lierop","year":"2013","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.metabol.2017.10.005_bb0090","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/ajmg.10401","article-title":"A 52-kb deletion in the SOST-MEOX1 intergenic region on 17q12-q21 is associated with van Buchem disease in the Dutch population","volume":"110","author":"Staehling-Hampton","year":"2002","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.metabol.2017.10.005_bb0095","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1086\/302416","article-title":"Localization of the gene for sclerosteosis to the van Buchem disease-gene region on chromosome 17q12-q21","volume":"64","author":"Balemans","year":"1999","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.metabol.2017.10.005_bb0100","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1086\/318811","article-title":"Bone dysplasia sclerosteosis results from loss of the SOST gene product, a novel cystine knot-containing protein","volume":"68","author":"Brunkow","year":"2001","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.metabol.2017.10.005_bb0105","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1093\/hmg\/10.5.537","article-title":"Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST)","volume":"10","author":"Balemans","year":"2001","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.metabol.2017.10.005_bb0110","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1136\/jmg.39.2.91","article-title":"Identification of a 52 kb deletion downstream of the SOST gene in patients with van Buchem disease","volume":"39","author":"Balemans","year":"2002","journal-title":"J Med Genet"},{"key":"10.1016\/j.metabol.2017.10.005_bb0115","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1089\/gte.2008.0036","article-title":"A known SOST gene mutation causes sclerosteosis in a familial and an isolated case from Brazilian origin","volume":"12","author":"Kim","year":"2008","journal-title":"Genet Test"},{"key":"10.1016\/j.metabol.2017.10.005_bb0120","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.bone.2005.02.019","article-title":"A generalized skeletal hyperostosis in two siblings caused by a novel mutation in the SOST gene","volume":"36","author":"Balemans","year":"2005","journal-title":"Bone"},{"key":"10.1016\/j.metabol.2017.10.005_bb0125","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.ejmg.2014.02.007","article-title":"Novel SOST gene mutation in a sclerosteosis patient from Morocco: a case report","volume":"57","author":"Belkhribchia","year":"2014","journal-title":"Eur J Med Genet"},{"key":"10.1016\/j.metabol.2017.10.005_bb0130","doi-asserted-by":"crossref","first-page":"E1526","DOI":"10.1002\/humu.21274","article-title":"First missense mutation in the SOST gene causing sclerosteosis by loss of sclerostin function","volume":"31","author":"Piters","year":"2010","journal-title":"Hum Mutat"},{"key":"10.1016\/j.metabol.2017.10.005_bb0135","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1007\/s00247-015-3292-1","article-title":"Sclerosteosis (craniotubular hyperostosis-syndactyly) with complex hyperphalangy of the index finger","volume":"45","author":"Yagi","year":"2015","journal-title":"Pediatr Radiol"},{"key":"10.1016\/j.metabol.2017.10.005_bb0140","doi-asserted-by":"crossref","first-page":"517815","DOI":"10.1155\/2015\/517815","article-title":"A Novel Loss-of-Sclerostin Function Mutation in a First Egyptian Family with Sclerosteosis","volume":"2015","author":"Fayez","year":"2015","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.metabol.2017.10.005_bb0145","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.bone.2012.10.009","article-title":"Novel SOST gene mutation in a sclerosteosis patient and her parents","volume":"52","author":"Bhadada","year":"2013","journal-title":"Bone"},{"key":"10.1016\/j.metabol.2017.10.005_bb0150","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/cge.12655","article-title":"Sclerosteosis caused by a novel nonsense mutation of SOST in a consanguineous family","volume":"89","author":"He","year":"2016","journal-title":"Clin Genet"},{"key":"10.1016\/j.metabol.2017.10.005_bb0155","doi-asserted-by":"crossref","first-page":"6392","DOI":"10.1210\/jc.2005-1235","article-title":"Bone mineral density in sclerosteosis; affected individuals and gene carriers","volume":"90","author":"Gardner","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2017.10.005_bb0160","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1101\/gr.3437105","article-title":"Genomic deletion of a long-range bone enhancer misregulates sclerostin in Van Buchem disease","volume":"15","author":"Loots","year":"2005","journal-title":"Genome Res"},{"key":"10.1016\/j.metabol.2017.10.005_bb0165","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.bone.2016.10.009","article-title":"Transcriptional control of Sost in bone","volume":"96","author":"Sebastian","year":"2017","journal-title":"Bone"},{"key":"10.1016\/j.metabol.2017.10.005_bb0170","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s11154-015-9311-6","article-title":"Sclerostin and skeletal health","volume":"16","author":"Sharifi","year":"2015","journal-title":"Rev Endocr Metab Disord"},{"key":"10.1016\/j.metabol.2017.10.005_bb0175","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.bone.2016.10.007","article-title":"Role and mechanism of action of sclerostin in bone","volume":"96","author":"Delgado-Calle","year":"2017","journal-title":"Bone"},{"key":"10.1016\/j.metabol.2017.10.005_bb0180","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/nrm3470","article-title":"The complex world of WNT receptor signalling","volume":"13","author":"Niehrs","year":"2012","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.metabol.2017.10.005_bb0185","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1086\/382196","article-title":"Homozygous WNT3 mutation causes tetra-amelia in a large consanguineous family","volume":"74","author":"Niemann","year":"2004","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.metabol.2017.10.005_bb0190","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/374350a0","article-title":"Dorsalizing signal Wnt-7a required for normal polarity of D-V and A-P axes of mouse limb","volume":"374","author":"Parr","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.metabol.2017.10.005_bb0195","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1002\/ajmg.a.33717","article-title":"A novel homozygous missense mutation (c.610G>A, p.Gly204Ser) in the WNT7A gene causes tetra-amelia in two Saudi families","volume":"155A","author":"Eyaid","year":"2011","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.metabol.2017.10.005_bb0200","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/bonekey.2012.1","article-title":"LRP5 and bone mass regulation: Where are we now?","volume":"1","author":"Johnson","year":"2012","journal-title":"Bonekey Rep"},{"key":"10.1016\/j.metabol.2017.10.005_bb0205","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1172\/JCI33612","article-title":"Building bone to reverse osteoporosis and repair fractures","volume":"118","author":"Khosla","year":"2008","journal-title":"J Clin Invest"},{"key":"10.1016\/j.metabol.2017.10.005_bb0210","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1359\/jbmr.080216","article-title":"Targeted deletion of the sclerostin gene in mice results in increased bone formation and bone strength","volume":"23","author":"Li","year":"2008","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.metabol.2017.10.005_bb0215","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1359\/jbmr.090730","article-title":"Parathyroid hormone (PTH)-induced bone gain is blunted in SOST overexpressing and deficient mice","volume":"25","author":"Kramer","year":"2010","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.metabol.2017.10.005_bb0220","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1002\/jbmr.2259","article-title":"Sclerostin deficiency is linked to altered bone composition","volume":"29","author":"Hassler","year":"2014","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.metabol.2017.10.005_bb0225","doi-asserted-by":"crossref","first-page":"6267","DOI":"10.1093\/emboj\/cdg599","article-title":"Osteocyte control of bone formation via sclerostin, a novel BMP antagonist","volume":"22","author":"Winkler","year":"2003","journal-title":"EMBO J"},{"key":"10.1016\/j.metabol.2017.10.005_bb0230","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.ydbio.2013.08.015","article-title":"Sost and its paralog Sostdc1 coordinate digit number in a Gli3-dependent manner","volume":"383","author":"Collette","year":"2013","journal-title":"Dev Biol"},{"key":"10.1016\/j.metabol.2017.10.005_bb0235","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.ydbio.2010.03.021","article-title":"Genetic evidence that SOST inhibits WNT signaling in the limb","volume":"342","author":"Collette","year":"2010","journal-title":"Dev Biol"},{"key":"10.1016\/j.metabol.2017.10.005_bb0240","doi-asserted-by":"crossref","first-page":"5866","DOI":"10.1074\/jbc.M705092200","article-title":"Mechanical stimulation of bone in vivo reduces osteocyte expression of Sost\/sclerostin","volume":"283","author":"Robling","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1016\/j.metabol.2017.10.005_bb0245","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1359\/jbmr.090411","article-title":"Sclerostin mediates bone response to mechanical unloading through antagonizing Wnt\/beta-catenin signaling","volume":"24","author":"Lin","year":"2009","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.metabol.2017.10.005_bb0250","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.bone.2011.10.025","article-title":"Sost downregulation and local Wnt signaling are required for the osteogenic response to mechanical loading","volume":"50","author":"Tu","year":"2012","journal-title":"Bone"},{"key":"10.1016\/j.metabol.2017.10.005_bb0255","doi-asserted-by":"crossref","first-page":"19489","DOI":"10.1074\/jbc.M110.190330","article-title":"Bone overgrowth-associated mutations in the LRP4 gene impair sclerostin facilitator function","volume":"286","author":"Leupin","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/j.metabol.2017.10.005_bb0260","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1002\/jbmr.2782","article-title":"A Novel Domain-Specific Mutation in a Sclerosteosis Patient Suggests a Role of LRP4 as an Anchor for Sclerostin in Human Bone","volume":"31","author":"Fijalkowski","year":"2016","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.metabol.2017.10.005_bb0265","doi-asserted-by":"crossref","first-page":"E5187","DOI":"10.1073\/pnas.1413828111","article-title":"Disruption of Lrp4 function by genetic deletion or pharmacological blockade increases bone mass and serum sclerostin levels","volume":"111","author":"Chang","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.metabol.2017.10.005_bb0270","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1002\/jbmr.3160","article-title":"The Lrp4R1170Q Homozygous Knock-In Mouse Recapitulates the Bone Phenotype of Sclerosteosis in Humans","volume":"32","author":"Boudin","year":"2017","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.metabol.2017.10.005_bb0275","doi-asserted-by":"crossref","first-page":"14092","DOI":"10.1073\/pnas.1207188109","article-title":"Targeted deletion of Sost distal enhancer increases bone formation and bone mass","volume":"109","author":"Collette","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.metabol.2017.10.005_bb0280","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/nrendo.2011.108","article-title":"Parathyroid hormone analogues in the treatment of osteoporosis","volume":"7","author":"Kraenzlin","year":"2011","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.metabol.2017.10.005_bb0285","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.bone.2005.03.018","article-title":"SOST is a target gene for PTH in bone","volume":"37","author":"Keller","year":"2005","journal-title":"Bone"},{"key":"10.1016\/j.metabol.2017.10.005_bb0290","doi-asserted-by":"crossref","first-page":"e2942","DOI":"10.1371\/journal.pone.0002942","article-title":"Control of bone mass and remodeling by PTH receptor signaling in osteocytes","volume":"3","author":"O'Brien","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.metabol.2017.10.005_bb0295","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1359\/jbmr.070804","article-title":"Control of the SOST bone enhancer by PTH using MEF2 transcription factors","volume":"22","author":"Leupin","year":"2007","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.metabol.2017.10.005_bb0300","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.coph.2010.04.004","article-title":"Regulatory signal transduction pathways for class IIa histone deacetylases","volume":"10","author":"Parra","year":"2010","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.metabol.2017.10.005_bb0305","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1002\/jbmr.2381","article-title":"HDAC5 controls MEF2C-driven sclerostin expression in osteocytes","volume":"30","author":"Wein","year":"2015","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.metabol.2017.10.005_bb0310","doi-asserted-by":"crossref","first-page":"13176","DOI":"10.1038\/ncomms13176","article-title":"SIKs control osteocyte responses to parathyroid hormone","volume":"7","author":"Wein","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/j.metabol.2017.10.005_bb0315","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/jbmr.173","article-title":"Single-dose, placebo-controlled, randomized study of AMG 785, a sclerostin monoclonal antibody","volume":"26","author":"Padhi","year":"2011","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.metabol.2017.10.005_bb0320","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1359\/jbmr.081206","article-title":"Sclerostin antibody treatment increases bone formation, bone mass, and bone strength in a rat model of postmenopausal osteoporosis","volume":"24","author":"Li","year":"2009","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.metabol.2017.10.005_bb0325","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1056\/NEJMoa1305224","article-title":"Romosozumab in postmenopausal women with low bone mineral density","volume":"370","author":"McClung","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.metabol.2017.10.005_bb0330","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1056\/NEJMoa1708322","article-title":"Romosozumab or Alendronate for Fracture Prevention in Women with Osteoporosis","volume":"377","author":"Saag","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.metabol.2017.10.005_bb0335","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s13075-015-0540-6","article-title":"Loss of sclerostin promotes osteoarthritis in mice via beta-catenin-dependent and -independent Wnt pathways","volume":"17","author":"Bouaziz","year":"2015","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.metabol.2017.10.005_bb0340","doi-asserted-by":"crossref","first-page":"330ra35","DOI":"10.1126\/scitranslmed.aac4351","article-title":"Sclerostin inhibition promotes TNF-dependent inflammatory joint destruction","volume":"8","author":"Wehmeyer","year":"2016","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.metabol.2017.10.005_bb0345","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1002\/jbmr.1608","article-title":"Absence of sclerostin adversely affects B cell survival","volume":"27","author":"Cain","year":"2012","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.metabol.2017.10.005_bb0350","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1097\/MOL.0000000000000445","article-title":"Wnt signaling in cardiovascular disease: opportunities and challenges","volume":"28","author":"Gay","year":"2017","journal-title":"Curr Opin Lipidol"}],"container-title":["Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049517302792?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049517302792?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T04:14:57Z","timestamp":1758428097000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026049517302792"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":70,"alternative-id":["S0026049517302792"],"URL":"https:\/\/doi.org\/10.1016\/j.metabol.2017.10.005","relation":{},"ISSN":["0026-0495"],"issn-type":[{"value":"0026-0495","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genetics of Sost\/SOST in sclerosteosis and van Buchem disease animal models","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2017.10.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}